From owner-diagnost@hgmp.mrc.ac.uk Thu Jan 8 14:08:41 2004 Return-Path: X-Original-To: diagnost-outgoing Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with SMTP id 44ABA7DA5B for ; Thu, 8 Jan 2004 14:08:41 +0000 (GMT) X-Original-To: diagnost-list@hgmp.mrc.ac.uk Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id CEF6F7DA56 for ; Thu, 8 Jan 2004 14:08:39 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6045) id EEC0D7DA49; Thu, 8 Jan 2004 14:08:31 +0000 (GMT) X-Original-To: bionet-diagnostics@net.bio.net Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1E7C97D3F3 for ; Fri, 5 Dec 2003 10:05:17 +0000 (GMT) Received: from trinity.supernews.net (trinity.ranger.supernews.net [216.168.1.22]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 6101D7D318 for ; Fri, 5 Dec 2003 10:05:12 +0000 (GMT) Received: from skirner.kfunigraz.ac.at ([143.50.206.163]:55223) by trinity.supernews.net with esmtp (Exim 4.20) id 1ASCpi-000CwS-Tu for bionet-diagnostics@moderators.isc.org; Fri, 05 Dec 2003 10:05:11 +0000 Received: (from news@localhost) by skirner.kfunigraz.ac.at (8.11.6/8.11.6) id hB58nPk20701 for bionet-diagnostics@moderators.isc.org; Fri, 5 Dec 2003 09:49:25 +0100 To: bionet-diagnostics@moderators.isc.org From: A Giessauf Newsgroups: bionet.diagnostics Subject: Virus purification project - search for partners Organization: Karl-Franzens-Universitaet Graz Message-ID: X-Trace: skirner.kfunigraz.ac.at 1070614165 20700 143.50.44.31 (5 Dec 2003 08:49:25 GMT) X-Complaints-To: postmaster@kfunigraz.ac.at NNTP-Posting-Date: Fri, 5 Dec 2003 08:49:25 +0000 (UTC) User-Agent: Mozilla/5.0 (Windows; U; Windows NT 5.0; de-DE; rv:1.4) Gecko/20030619 Netscape/7.1 (ax) X-Accept-Language: de-de, de X-MIME-Autoconverted: from 8bit to quoted-printable by skirner.kfunigraz.ac.at id hB58nPk20701 Date: Thu, 8 Jan 2004 14:08:31 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Dear all, I am about starting to write a proposal for a research project about a novel method for isolation / purification of virus particles from cell culture supernatants for use as antigens for diagnostic assay production. I have published the first article on this method "A technique for isolation of rubella virus-like particles by sucrose gradient ultracentrifugation using Coomassie brilliant blue G crystals" last year (Anal.Biochem. 308 (2002) 232-238) and I am searching now for (1) interested international research partners, who can provide me with stable transfected cell lines (or other expression systems) that secretes any virus-like particles that may become by my research more interesting for use as an antigen for assay production. I will try to carry forward the technique from the already described method for Rubella virus purification also to other virus particles. Density gradient ultracentrifugation has to be the final purification step. (2) Any industrial research partners that are interested to test antigens for assay production (e.g. immunoblot test stripes) are also welcome and will be mentioned in my research proposal. The advantage for an industrial partner in such a collaboration will be to obtain antigens at a lower price and the greatest part of the developing work will be done by my research work. Please contact my as soon as possible if you are interested , any comments or ideas are welcome. Sincerely yours, Andreas Gießauf, PhD andreas.giessauf@uni-graz.at .